Article Text

Download PDFPDF
Once weekly thyroxine treatment as a strategy to treat non-compliance
  1. S Rangan,
  2. A A Tahrani,
  3. A F Macleod,
  4. P K Moulik
  1. Department of Diabetes and Endocrinology, Royal Shrewsbury Hospital, Shrewsbury, UK
  1. Dr A A Tahrani, The Hummingbird Centre, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury SY3 8XQ, UK; abdtahrani{at}


Hypothyroidism is a common disorder, which is mainly treated in primary rather than secondary care. Once daily thyroxine replacement restores euthyroidism in most patients; some patients, however, remain hypothyroid despite adequate thyroxine replacement. Non-compliance is the most common cause of lack of response to thyroxine treatment. We describe two cases of primary hypothyroidism in which daily thyroxine treatment did not restore biochemical euthyroidism but once weekly thyroxine treatment was successful. In addition we review the evidence and discuss the differential diagnosis of lack of response to thyroxine treatment. Once weekly thyroxine treatment can be a safe, well-tolerated, and effective therapy for patients with non-compliance.

  • hypothyroidism
  • thyroxine
  • thyroxine replacement
  • non-compliance

Statistics from


  • Conflict of interest: None

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.